跳至主要内容
临床试验/ACTRN12619001186145
ACTRN12619001186145招募中1 期

Treatment of Locally Advanced non-small cell lung carcinoma with Stereotactic ablativE Radiotherapy

Alfred Health0 个研究点目标入组 27 人开始时间: 2019年8月22日最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
Alfred Health
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of stage III or IV non-small cell lung carcinoma. Based on clinical or histologic grounds.
  • - Ineligible for standard of care concurrent chemoradiotherapy as determined by a multidisciplinary group.
  • - Estimated life expectancy >6 months. Scoring using a Victorian Lung Cancer Prognostic Index is suggested for guidance.
  • - Recommended a course of radiotherapy to the lung and mediastinal disease.
  • - Over 18 years of age and available for follow up.

排除标准

  • - Previous radiotherapy to the chest.
  • - History of another primary cancer within the last 2 years, with the exception of non-melanomatous skin cancer and carcinoma in situ of the cervix.
  • - Significant medical conditions which in the opinion of the investigator would compromise the planned delivery of the radiotherapy or which may be potentially exacerbated by the treatment.
  • - Pregnant or breast feeding.

研究者

发起方
Alfred Health

相似试验